This research study is collecting and analyzing lung tissue samples from patients undergoing surgery for non-small cell lung cancer. The goal is to learn more about changes in RNA (a molecule important for making proteins) and identify biomarkers (biological signs) related to cancer. Researchers will use techniques like gene expression analysis, microarray analysis, and protein expression analysis on blood and lung tissue samples. You may be able to join if you are 18 to 120 years old, have non-small cell lung cancer that is clinical stage I or II, and are planning to have surgery to remove the cancer. The study aims to understand the protein and RNA patterns in these samples. The current status of this study is unclear, and it plans to enroll 4000 participants.

Study design

This is an observational, multicenter study. It plans to enroll 4000 participants.

What's involved

If you participate, excess tissue from your surgery that would normally be discarded will be collected. Your medical records will also be reviewed to gather information about your cancer diagnosis and treatment progress.

Compensation

Not stated in the trial record.

Follow-up

Your medical records will be reviewed to follow your progress in cancer treatment and tumor behavior after surgery, including recurrence and survival.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.